Global Human Blood Plasma Fractionation Supply, Demand and Key Producers, 2024-2030

Description

The global Human Blood Plasma Fractionation market size is expected to reach $ 51020 million by 2030, rising at a market growth of 7.3% CAGR during the forecast period (2024-2030).

The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
This report studies the global Human Blood Plasma Fractionation demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Blood Plasma Fractionation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Blood Plasma Fractionation that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Blood Plasma Fractionation total market, 2019-2030, (USD Million)
Global Human Blood Plasma Fractionation total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Human Blood Plasma Fractionation total market, key domestic companies and share, (USD Million)
Global Human Blood Plasma Fractionation revenue by player and market share 2019-2024, (USD Million)
Global Human Blood Plasma Fractionation total market by Type, CAGR, 2019-2030, (USD Million)
Global Human Blood Plasma Fractionation total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Human Blood Plasma Fractionation market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Blood Plasma Fractionation market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Blood Plasma Fractionation Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Blood Plasma Fractionation Market, Segmentation by Type
    Immune Globulin
    Coagulation Factor
    Albumin
    Others

Global Human Blood Plasma Fractionation Market, Segmentation by Application
    Hospital
    Retail Pharmacy
    Others

Companies Profiled:
    Takeda
    CSL
    Grifols
    Octapharma
    Kedrion
    LFB Group
    Biotest
    BPL
    RAAS
    CBPO
    Hualan Bio
    Tiantan Bio
    Shuanglin Bio
    Boya Bio
    Yuanda Shuyang
    Weiguang Bio
    Nanyue Bio
    KM Biologics

Key Questions Answered
1. How big is the global Human Blood Plasma Fractionation market?
2. What is the demand of the global Human Blood Plasma Fractionation market?
3. What is the year over year growth of the global Human Blood Plasma Fractionation market?
4. What is the total value of the global Human Blood Plasma Fractionation market?
5. Who are the major players in the global Human Blood Plasma Fractionation market?

Table of Contents

1 Supply Summary
    1.1 Human Blood Plasma Fractionation Introduction
    1.2 World Human Blood Plasma Fractionation Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Human Blood Plasma Fractionation Total Market by Region (by Headquarter Location)
        1.3.1 World Human Blood Plasma Fractionation Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.3 China Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.4 Europe Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.5 Japan Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.6 South Korea Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.7 ASEAN Human Blood Plasma Fractionation Market Size (2019-2030)
        1.3.8 India Human Blood Plasma Fractionation Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Blood Plasma Fractionation Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Human Blood Plasma Fractionation Major Market Trends

2 Demand Summary
    2.1 World Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.2 World Human Blood Plasma Fractionation Consumption Value by Region
        2.2.1 World Human Blood Plasma Fractionation Consumption Value by Region (2019-2024)
        2.2.2 World Human Blood Plasma Fractionation Consumption Value Forecast by Region (2025-2030)
    2.3 United States Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.4 China Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.5 Europe Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.6 Japan Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.7 South Korea Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.8 ASEAN Human Blood Plasma Fractionation Consumption Value (2019-2030)
    2.9 India Human Blood Plasma Fractionation Consumption Value (2019-2030)

3 World Human Blood Plasma Fractionation Companies Competitive Analysis
    3.1 World Human Blood Plasma Fractionation Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Blood Plasma Fractionation Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Blood Plasma Fractionation in 2023
        3.2.3 Global Concentration Ratios (CR8) for Human Blood Plasma Fractionation in 2023
    3.3 Human Blood Plasma Fractionation Company Evaluation Quadrant
    3.4 Human Blood Plasma Fractionation Market: Overall Company Footprint Analysis
        3.4.1 Human Blood Plasma Fractionation Market: Region Footprint
        3.4.2 Human Blood Plasma Fractionation Market: Company Product Type Footprint
        3.4.3 Human Blood Plasma Fractionation Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Human Blood Plasma Fractionation Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Blood Plasma Fractionation Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Human Blood Plasma Fractionation Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Human Blood Plasma Fractionation Consumption Value Comparison
        4.2.1 United States VS China: Human Blood Plasma Fractionation Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Blood Plasma Fractionation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Human Blood Plasma Fractionation Companies and Market Share, 2019-2024
        4.3.1 United States Based Human Blood Plasma Fractionation Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024)
    4.4 China Based Companies Human Blood Plasma Fractionation Revenue and Market Share, 2019-2024
        4.4.1 China Based Human Blood Plasma Fractionation Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024)
    4.5 Rest of World Based Human Blood Plasma Fractionation Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Human Blood Plasma Fractionation Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Human Blood Plasma Fractionation Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Immune Globulin
        5.2.2 Coagulation Factor
        5.2.3 Albumin
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Human Blood Plasma Fractionation Market Size by Type (2019-2024)
        5.3.2 World Human Blood Plasma Fractionation Market Size by Type (2025-2030)
        5.3.3 World Human Blood Plasma Fractionation Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Human Blood Plasma Fractionation Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Retail Pharmacy
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Human Blood Plasma Fractionation Market Size by Application (2019-2024)
        6.3.2 World Human Blood Plasma Fractionation Market Size by Application (2025-2030)
        6.3.3 World Human Blood Plasma Fractionation Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Takeda
        7.1.1 Takeda Details
        7.1.2 Takeda Major Business
        7.1.3 Takeda Human Blood Plasma Fractionation Product and Services
        7.1.4 Takeda Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Takeda Recent Developments/Updates
        7.1.6 Takeda Competitive Strengths & Weaknesses
    7.2 CSL
        7.2.1 CSL Details
        7.2.2 CSL Major Business
        7.2.3 CSL Human Blood Plasma Fractionation Product and Services
        7.2.4 CSL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 CSL Recent Developments/Updates
        7.2.6 CSL Competitive Strengths & Weaknesses
    7.3 Grifols
        7.3.1 Grifols Details
        7.3.2 Grifols Major Business
        7.3.3 Grifols Human Blood Plasma Fractionation Product and Services
        7.3.4 Grifols Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Grifols Recent Developments/Updates
        7.3.6 Grifols Competitive Strengths & Weaknesses
    7.4 Octapharma
        7.4.1 Octapharma Details
        7.4.2 Octapharma Major Business
        7.4.3 Octapharma Human Blood Plasma Fractionation Product and Services
        7.4.4 Octapharma Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Octapharma Recent Developments/Updates
        7.4.6 Octapharma Competitive Strengths & Weaknesses
    7.5 Kedrion
        7.5.1 Kedrion Details
        7.5.2 Kedrion Major Business
        7.5.3 Kedrion Human Blood Plasma Fractionation Product and Services
        7.5.4 Kedrion Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Kedrion Recent Developments/Updates
        7.5.6 Kedrion Competitive Strengths & Weaknesses
    7.6 LFB Group
        7.6.1 LFB Group Details
        7.6.2 LFB Group Major Business
        7.6.3 LFB Group Human Blood Plasma Fractionation Product and Services
        7.6.4 LFB Group Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 LFB Group Recent Developments/Updates
        7.6.6 LFB Group Competitive Strengths & Weaknesses
    7.7 Biotest
        7.7.1 Biotest Details
        7.7.2 Biotest Major Business
        7.7.3 Biotest Human Blood Plasma Fractionation Product and Services
        7.7.4 Biotest Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Biotest Recent Developments/Updates
        7.7.6 Biotest Competitive Strengths & Weaknesses
    7.8 BPL
        7.8.1 BPL Details
        7.8.2 BPL Major Business
        7.8.3 BPL Human Blood Plasma Fractionation Product and Services
        7.8.4 BPL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 BPL Recent Developments/Updates
        7.8.6 BPL Competitive Strengths & Weaknesses
    7.9 RAAS
        7.9.1 RAAS Details
        7.9.2 RAAS Major Business
        7.9.3 RAAS Human Blood Plasma Fractionation Product and Services
        7.9.4 RAAS Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 RAAS Recent Developments/Updates
        7.9.6 RAAS Competitive Strengths & Weaknesses
    7.10 CBPO
        7.10.1 CBPO Details
        7.10.2 CBPO Major Business
        7.10.3 CBPO Human Blood Plasma Fractionation Product and Services
        7.10.4 CBPO Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 CBPO Recent Developments/Updates
        7.10.6 CBPO Competitive Strengths & Weaknesses
    7.11 Hualan Bio
        7.11.1 Hualan Bio Details
        7.11.2 Hualan Bio Major Business
        7.11.3 Hualan Bio Human Blood Plasma Fractionation Product and Services
        7.11.4 Hualan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Hualan Bio Recent Developments/Updates
        7.11.6 Hualan Bio Competitive Strengths & Weaknesses
    7.12 Tiantan Bio
        7.12.1 Tiantan Bio Details
        7.12.2 Tiantan Bio Major Business
        7.12.3 Tiantan Bio Human Blood Plasma Fractionation Product and Services
        7.12.4 Tiantan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Tiantan Bio Recent Developments/Updates
        7.12.6 Tiantan Bio Competitive Strengths & Weaknesses
    7.13 Shuanglin Bio
        7.13.1 Shuanglin Bio Details
        7.13.2 Shuanglin Bio Major Business
        7.13.3 Shuanglin Bio Human Blood Plasma Fractionation Product and Services
        7.13.4 Shuanglin Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Shuanglin Bio Recent Developments/Updates
        7.13.6 Shuanglin Bio Competitive Strengths & Weaknesses
    7.14 Boya Bio
        7.14.1 Boya Bio Details
        7.14.2 Boya Bio Major Business
        7.14.3 Boya Bio Human Blood Plasma Fractionation Product and Services
        7.14.4 Boya Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Boya Bio Recent Developments/Updates
        7.14.6 Boya Bio Competitive Strengths & Weaknesses
    7.15 Yuanda Shuyang
        7.15.1 Yuanda Shuyang Details
        7.15.2 Yuanda Shuyang Major Business
        7.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Product and Services
        7.15.4 Yuanda Shuyang Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Yuanda Shuyang Recent Developments/Updates
        7.15.6 Yuanda Shuyang Competitive Strengths & Weaknesses
    7.16 Weiguang Bio
        7.16.1 Weiguang Bio Details
        7.16.2 Weiguang Bio Major Business
        7.16.3 Weiguang Bio Human Blood Plasma Fractionation Product and Services
        7.16.4 Weiguang Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Weiguang Bio Recent Developments/Updates
        7.16.6 Weiguang Bio Competitive Strengths & Weaknesses
    7.17 Nanyue Bio
        7.17.1 Nanyue Bio Details
        7.17.2 Nanyue Bio Major Business
        7.17.3 Nanyue Bio Human Blood Plasma Fractionation Product and Services
        7.17.4 Nanyue Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Nanyue Bio Recent Developments/Updates
        7.17.6 Nanyue Bio Competitive Strengths & Weaknesses
    7.18 KM Biologics
        7.18.1 KM Biologics Details
        7.18.2 KM Biologics Major Business
        7.18.3 KM Biologics Human Blood Plasma Fractionation Product and Services
        7.18.4 KM Biologics Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 KM Biologics Recent Developments/Updates
        7.18.6 KM Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Blood Plasma Fractionation Industry Chain
    8.2 Human Blood Plasma Fractionation Upstream Analysis
    8.3 Human Blood Plasma Fractionation Midstream Analysis
    8.4 Human Blood Plasma Fractionation Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Human Blood Plasma Fractionation Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Human Blood Plasma Fractionation Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Human Blood Plasma Fractionation Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Human Blood Plasma Fractionation Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Human Blood Plasma Fractionation Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Human Blood Plasma Fractionation Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Human Blood Plasma Fractionation Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Human Blood Plasma Fractionation Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Human Blood Plasma Fractionation Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Human Blood Plasma Fractionation Players in 2023
    Table 12. World Human Blood Plasma Fractionation Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Human Blood Plasma Fractionation Company Evaluation Quadrant
    Table 14. Head Office of Key Human Blood Plasma Fractionation Player
    Table 15. Human Blood Plasma Fractionation Market: Company Product Type Footprint
    Table 16. Human Blood Plasma Fractionation Market: Company Product Application Footprint
    Table 17. Human Blood Plasma Fractionation Mergers & Acquisitions Activity
    Table 18. United States VS China Human Blood Plasma Fractionation Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Human Blood Plasma Fractionation Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Human Blood Plasma Fractionation Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Human Blood Plasma Fractionation Revenue Market Share (2019-2024)
    Table 23. China Based Human Blood Plasma Fractionation Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Human Blood Plasma Fractionation Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Human Blood Plasma Fractionation Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Human Blood Plasma Fractionation Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Human Blood Plasma Fractionation Revenue Market Share (2019-2024)
    Table 29. World Human Blood Plasma Fractionation Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Human Blood Plasma Fractionation Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Human Blood Plasma Fractionation Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Human Blood Plasma Fractionation Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Human Blood Plasma Fractionation Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Human Blood Plasma Fractionation Market Size by Application (2025-2030) & (USD Million)
    Table 35. Takeda Basic Information, Area Served and Competitors
    Table 36. Takeda Major Business
    Table 37. Takeda Human Blood Plasma Fractionation Product and Services
    Table 38. Takeda Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Takeda Recent Developments/Updates
    Table 40. Takeda Competitive Strengths & Weaknesses
    Table 41. CSL Basic Information, Area Served and Competitors
    Table 42. CSL Major Business
    Table 43. CSL Human Blood Plasma Fractionation Product and Services
    Table 44. CSL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. CSL Recent Developments/Updates
    Table 46. CSL Competitive Strengths & Weaknesses
    Table 47. Grifols Basic Information, Area Served and Competitors
    Table 48. Grifols Major Business
    Table 49. Grifols Human Blood Plasma Fractionation Product and Services
    Table 50. Grifols Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Grifols Recent Developments/Updates
    Table 52. Grifols Competitive Strengths & Weaknesses
    Table 53. Octapharma Basic Information, Area Served and Competitors
    Table 54. Octapharma Major Business
    Table 55. Octapharma Human Blood Plasma Fractionation Product and Services
    Table 56. Octapharma Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Octapharma Recent Developments/Updates
    Table 58. Octapharma Competitive Strengths & Weaknesses
    Table 59. Kedrion Basic Information, Area Served and Competitors
    Table 60. Kedrion Major Business
    Table 61. Kedrion Human Blood Plasma Fractionation Product and Services
    Table 62. Kedrion Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Kedrion Recent Developments/Updates
    Table 64. Kedrion Competitive Strengths & Weaknesses
    Table 65. LFB Group Basic Information, Area Served and Competitors
    Table 66. LFB Group Major Business
    Table 67. LFB Group Human Blood Plasma Fractionation Product and Services
    Table 68. LFB Group Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. LFB Group Recent Developments/Updates
    Table 70. LFB Group Competitive Strengths & Weaknesses
    Table 71. Biotest Basic Information, Area Served and Competitors
    Table 72. Biotest Major Business
    Table 73. Biotest Human Blood Plasma Fractionation Product and Services
    Table 74. Biotest Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Biotest Recent Developments/Updates
    Table 76. Biotest Competitive Strengths & Weaknesses
    Table 77. BPL Basic Information, Area Served and Competitors
    Table 78. BPL Major Business
    Table 79. BPL Human Blood Plasma Fractionation Product and Services
    Table 80. BPL Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. BPL Recent Developments/Updates
    Table 82. BPL Competitive Strengths & Weaknesses
    Table 83. RAAS Basic Information, Area Served and Competitors
    Table 84. RAAS Major Business
    Table 85. RAAS Human Blood Plasma Fractionation Product and Services
    Table 86. RAAS Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. RAAS Recent Developments/Updates
    Table 88. RAAS Competitive Strengths & Weaknesses
    Table 89. CBPO Basic Information, Area Served and Competitors
    Table 90. CBPO Major Business
    Table 91. CBPO Human Blood Plasma Fractionation Product and Services
    Table 92. CBPO Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. CBPO Recent Developments/Updates
    Table 94. CBPO Competitive Strengths & Weaknesses
    Table 95. Hualan Bio Basic Information, Area Served and Competitors
    Table 96. Hualan Bio Major Business
    Table 97. Hualan Bio Human Blood Plasma Fractionation Product and Services
    Table 98. Hualan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Hualan Bio Recent Developments/Updates
    Table 100. Hualan Bio Competitive Strengths & Weaknesses
    Table 101. Tiantan Bio Basic Information, Area Served and Competitors
    Table 102. Tiantan Bio Major Business
    Table 103. Tiantan Bio Human Blood Plasma Fractionation Product and Services
    Table 104. Tiantan Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Tiantan Bio Recent Developments/Updates
    Table 106. Tiantan Bio Competitive Strengths & Weaknesses
    Table 107. Shuanglin Bio Basic Information, Area Served and Competitors
    Table 108. Shuanglin Bio Major Business
    Table 109. Shuanglin Bio Human Blood Plasma Fractionation Product and Services
    Table 110. Shuanglin Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Shuanglin Bio Recent Developments/Updates
    Table 112. Shuanglin Bio Competitive Strengths & Weaknesses
    Table 113. Boya Bio Basic Information, Area Served and Competitors
    Table 114. Boya Bio Major Business
    Table 115. Boya Bio Human Blood Plasma Fractionation Product and Services
    Table 116. Boya Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Boya Bio Recent Developments/Updates
    Table 118. Boya Bio Competitive Strengths & Weaknesses
    Table 119. Yuanda Shuyang Basic Information, Area Served and Competitors
    Table 120. Yuanda Shuyang Major Business
    Table 121. Yuanda Shuyang Human Blood Plasma Fractionation Product and Services
    Table 122. Yuanda Shuyang Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. Yuanda Shuyang Recent Developments/Updates
    Table 124. Yuanda Shuyang Competitive Strengths & Weaknesses
    Table 125. Weiguang Bio Basic Information, Area Served and Competitors
    Table 126. Weiguang Bio Major Business
    Table 127. Weiguang Bio Human Blood Plasma Fractionation Product and Services
    Table 128. Weiguang Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. Weiguang Bio Recent Developments/Updates
    Table 130. Weiguang Bio Competitive Strengths & Weaknesses
    Table 131. Nanyue Bio Basic Information, Area Served and Competitors
    Table 132. Nanyue Bio Major Business
    Table 133. Nanyue Bio Human Blood Plasma Fractionation Product and Services
    Table 134. Nanyue Bio Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Nanyue Bio Recent Developments/Updates
    Table 136. KM Biologics Basic Information, Area Served and Competitors
    Table 137. KM Biologics Major Business
    Table 138. KM Biologics Human Blood Plasma Fractionation Product and Services
    Table 139. KM Biologics Human Blood Plasma Fractionation Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 140. Global Key Players of Human Blood Plasma Fractionation Upstream (Raw Materials)
    Table 141. Human Blood Plasma Fractionation Typical Customers
List of Figure
    Figure 1. Human Blood Plasma Fractionation Picture
    Figure 2. World Human Blood Plasma Fractionation Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Human Blood Plasma Fractionation Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Human Blood Plasma Fractionation Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Human Blood Plasma Fractionation Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Human Blood Plasma Fractionation Revenue (2019-2030) & (USD Million)
    Figure 13. Human Blood Plasma Fractionation Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Human Blood Plasma Fractionation Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Human Blood Plasma Fractionation Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Human Blood Plasma Fractionation by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Blood Plasma Fractionation Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Blood Plasma Fractionation Markets in 2023
    Figure 27. United States VS China: Human Blood Plasma Fractionation Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Human Blood Plasma Fractionation Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Human Blood Plasma Fractionation Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Human Blood Plasma Fractionation Market Size Market Share by Type in 2023
    Figure 31. Immune Globulin
    Figure 32. Coagulation Factor
    Figure 33. Albumin
    Figure 34. Others
    Figure 35. World Human Blood Plasma Fractionation Market Size Market Share by Type (2019-2030)
    Figure 36. World Human Blood Plasma Fractionation Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Human Blood Plasma Fractionation Market Size Market Share by Application in 2023
    Figure 38. Hospital
    Figure 39. Retail Pharmacy
    Figure 40. Others
    Figure 41. Human Blood Plasma Fractionation Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics